Anatomy and Normal Mitral Valve Function
The mitral valve consists of four main components that work together to prevent backflow. These include the annulus (fibrous ring anchoring the leaflets), the leaflets (anterior and posterior), the chordae tendinae (supporting cables), and the papillary muscles (muscular attachments).
How the Valve Opens and Closes
During diastole, the valve opens to allow blood flow from the left atrium to the left ventricle. During systole, the papillary muscles contract and tense the chordae tendinae. This tension prevents the leaflets from prolapsing into the atrium as ventricular pressure rises. The leaflets then seal tightly at the coaptation point, preventing any backflow.
Key Structural Features
The anterior leaflet is larger and more mobile than the posterior leaflet. The annulus can change shape and size in response to ventricular dilatation. When any structural or geometric change disrupts the leaflet relationship, mitral regurgitation develops.
Understanding this anatomy is critical because pathology affecting any single component can result in mitral regurgitation. The normal mitral valve closes with minimal regurgitant flow. Pathophysiological changes can transform a competent valve into an incompetent one.
Primary Mitral Regurgitation: Organic Valve Pathology
Primary mitral regurgitation results from intrinsic abnormalities of the valve apparatus itself. The valve leaflets, chordae, annulus, or papillary muscles are damaged or structurally abnormal. This is distinct from secondary MR, where the valve is normal but geometric changes cause dysfunction.
Common Causes of Primary MR
- Mitral valve prolapse (MVP): One or both leaflets bulge into the left atrium during systole. Affects 1-2% of the population. Often associated with myxomatous degeneration (tissue breakdown and weakening).
- Rheumatic heart disease: Acute rheumatic fever causes inflammation and scarring, stiffening and retracting the leaflets. Makes coaptation incomplete.
- Infective endocarditis: Vegetations destroy valve tissue, causing acute severe regurgitation. Requires urgent intervention.
- Degenerative calcification: More common in elderly patients. Prevents complete leaflet coaptation.
- Congenital abnormalities: Cleft mitral valve or other developmental defects.
- Connective tissue disorders: Marfan syndrome and similar conditions predispose to myxomatous changes.
Why Distinguishing Primary MR Matters
In primary mitral regurgitation, the underlying problem is with valve structure, not the ventricle. This distinction is crucial because primary MR may progress to severe disease requiring surgical repair or replacement. Secondary MR (discussed next) might improve if the underlying ventricular dysfunction is treated. Each cause produces regurgitation through different mechanisms, but all result in incomplete valve closure during systole.
Secondary Mitral Regurgitation: Functional Valve Incompetence
Secondary mitral regurgitation occurs when a structurally normal valve becomes incompetent due to geometric distortion of the left ventricle or annulus. The problem is not with valve structure but with the geometric relationship between valve components.
How Ventricular Dilatation Causes MR
Left ventricular dilatation enlarges the mitral annulus and displaces the papillary muscles outward and backward. The leaflets fail to meet completely (incomplete coaptation) even though they are structurally normal. The papillary muscles become too stretched to properly tension the chordae tendinae.
Common Causes of Secondary MR
- Dilated cardiomyopathy from any cause
- Myocardial infarction, especially posterior wall affecting the posteromedial papillary muscle
- Aortic regurgitation causing left ventricular dilatation
- Uncontrolled hypertension over many years
- Ischemic heart disease with ventricular dysfunction
- Atrial fibrillation promoting left atrial and ventricular dilatation
Why This Distinction Has Therapeutic Importance
Treating the underlying cause of ventricular dilatation might reduce or resolve the mitral regurgitation. For example, revascularization in ischemic cardiomyopathy or blood pressure control in hypertensive patients might improve mitral competence. Secondary MR is often dynamic, meaning the degree of regurgitation changes with loading conditions and contractility. During states of increased contractility, the papillary muscles function better and regurgitation may decrease. Echocardiographic assessment must consider the clinical context when quantifying secondary MR.
Hemodynamic Consequences and Compensatory Mechanisms
Mitral regurgitation creates a regurgitant jet that flows backward into the left atrium during systole. This immediately increases left atrial pressure and volume. The left atrium must handle both the normal forward flow from the pulmonary veins and the regurgitant flow from the left ventricle.
Acute versus Chronic Changes
In acute mitral regurgitation, the unprepared left atrium experiences sudden pressure elevation. This can cause pulmonary edema and hemodynamic instability. The cardiovascular system has no time to adapt to the sudden volume load.
In chronic mitral regurgitation, structural remodeling allows compensation for years before symptoms develop. The left atrium dilates to accommodate increased volume. The left ventricle develops eccentric hypertrophy (chamber enlargement without proportional wall thickening) as it adapts to chronic volume overload.
Progressive Ventricular Changes
The left ventricular end-diastolic volume increases because the regurgitant volume is added to the normal stroke volume. Initially, ventricular dilatation preserves function through the Frank-Starling mechanism. However, progressive dilatation eventually leads to systolic dysfunction and reduced ejection fraction.
The regurgitant fraction (ratio of regurgitant volume to total left ventricular stroke volume) determines severity. As regurgitation worsens, the ventricle becomes less efficient and systemic perfusion decreases. Ventricular function eventually deteriorates even if regurgitation is corrected surgically. Early intervention before irreversible ventricular damage occurs is crucial for preserving long-term outcomes.
Clinical Presentation, Diagnosis, and Management Principles
Mild to moderate chronic mitral regurgitation is often asymptomatic and discovered incidentally on auscultation or imaging. Severe mitral regurgitation or acute presentations cause dyspnea, fatigue, orthopnea, and signs of heart failure. Atrial fibrillation frequently develops due to atrial enlargement.
Physical Examination Findings
The classic physical finding is a holosystolic (pansystolic) murmur at the apex that radiates to the axilla. This murmur is audible throughout systole and distinguishes mitral regurgitation from other cardiac murmurs. In acute presentations from endocarditis or papillary muscle rupture, patients present with acute pulmonary edema and cardiogenic shock.
Diagnostic Approach
Transthoracic echocardiography is the gold standard diagnostic tool. It quantifies regurgitant volume, effective regurgitant orifice area, and left ventricular dimensions. Color Doppler demonstrates the regurgitant jet area and direction. Cardiac catheterization shows prominent systolic cv waves in the pulmonary artery wedge pressure tracing.
Management Based on Severity
Management depends on symptom status and ventricular function. Asymptomatic patients with preserved ventricular function require monitoring and blood pressure control. Symptomatic patients or those with ventricular dilatation or dysfunction warrant consideration of surgical repair or replacement.
Mitral valve repair is preferable to replacement when anatomically feasible because it preserves ventricular function. Medical management includes diuretics for pulmonary congestion, ACE inhibitors to reduce afterload, and rate control for atrial fibrillation. Understanding natural history and appropriate intervention timing prevents irreversible ventricular damage.
